Back to all articles

Oral presentations ECCO 2022

Scientific session 1 : developing environmental recipes for IBD », Journal of Crohn’s and Colitis, 2022 – established in the context of Dissemination portfolio 2022 of the BIOCYCLE project.

For more information: BIOCYCLE website: biocycle-project.eu EU reference: grant agreement No 633168 – BIOCYCLE (PHC-13-2014)

Click here spare ECCO 2022

Continue to read

Distinct biological profiles associated with the risk of short-term relapse and mid/long-term relapse in Crohn’s disease patients stopping infliximab.

10 janvier 2023

ECCO Topical Review on Biological Treatment Cycles in Crohn’s Disease.

A serum metabolite panel predicts Crohn’s disease relapse in patients discontinuing infliximab and continuing antimetabolite therapy: sub-analysis of the SPARE Trial.